Objective: It is well known that receipt of an initial abnormal cervical cytology test can trigger considerable anxiety among women. Less is known about the impact of follow-up by repeat cytology tests. We quantified prevalence, and identified predictors, of distress after repeat cytologic testing in women with a single low-grade test.Methods: Within the framework of the TOMBOLA randomized controlled trial of alternative managements, 844 women aged 20 to 59 years with a single routine cytology test showing borderline nuclear abnormalities (BNA; broadly equivalent to atypical squamous cells of undetermined significance) were assigned to follow-up by repeat cytology in primary care (the first test was due 6 months after the initial BNA result...
BACKGROUND: A colposcopy examination is the main management option for women with an abnormal cervic...
Objective To describe the psychological impact on women of being tested for human papillomavirus (HP...
Purpose: Low-grade abnormalities after cervical cancer screening, i.e. borderline (Pap 2) or mildly ...
Objective: It is well known that receipt of an initial abnormal cervical cytology test can trigger c...
BACKGROUND: Large numbers of women who participate in cervical screening require follow-up for minor...
Large numbers of women who participate in cervical screening require follow-up for minor cytological...
OBJECTIVE: Worldwide, each year, large numbers of women are referred for colposcopy following low-gr...
OBJECTIVE: To compare psychosocial outcomes (follow-up related worries and satisfaction with follow-...
We used a cross-sectional survey to examine short-term anxiety and distress in women receiving diffe...
We are grateful for the co-operation and assistance that we received from NHS staff in the co-ordina...
Objective To compare psychosocial outcomes (follow-up related worries, and satisfaction with follow-...
OBJECTIVES: Many countries are now using primary human papillomavirus (HPV) testing for cervical scr...
Background: There is a need for an instrument to measure the psychosocial burden of receiving an abn...
OBJECTIVE: To describe the psychological impact on women of being tested for human papillomavirus (H...
Background: A colposcopy examination is the main management option for women with an abnormal cervic...
BACKGROUND: A colposcopy examination is the main management option for women with an abnormal cervic...
Objective To describe the psychological impact on women of being tested for human papillomavirus (HP...
Purpose: Low-grade abnormalities after cervical cancer screening, i.e. borderline (Pap 2) or mildly ...
Objective: It is well known that receipt of an initial abnormal cervical cytology test can trigger c...
BACKGROUND: Large numbers of women who participate in cervical screening require follow-up for minor...
Large numbers of women who participate in cervical screening require follow-up for minor cytological...
OBJECTIVE: Worldwide, each year, large numbers of women are referred for colposcopy following low-gr...
OBJECTIVE: To compare psychosocial outcomes (follow-up related worries and satisfaction with follow-...
We used a cross-sectional survey to examine short-term anxiety and distress in women receiving diffe...
We are grateful for the co-operation and assistance that we received from NHS staff in the co-ordina...
Objective To compare psychosocial outcomes (follow-up related worries, and satisfaction with follow-...
OBJECTIVES: Many countries are now using primary human papillomavirus (HPV) testing for cervical scr...
Background: There is a need for an instrument to measure the psychosocial burden of receiving an abn...
OBJECTIVE: To describe the psychological impact on women of being tested for human papillomavirus (H...
Background: A colposcopy examination is the main management option for women with an abnormal cervic...
BACKGROUND: A colposcopy examination is the main management option for women with an abnormal cervic...
Objective To describe the psychological impact on women of being tested for human papillomavirus (HP...
Purpose: Low-grade abnormalities after cervical cancer screening, i.e. borderline (Pap 2) or mildly ...